| Raymond Chiong, DO | |
|
36 Prospect Ave, Valhalla, NY 10595-1910 | |
| (914) 761-6257 | |
| Not Available |
| Full Name | Raymond Chiong |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 12 Years |
| Location | 36 Prospect Ave, Valhalla, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245592435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 274411 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
To influence congressional candidates up for election this November, a group of mental health activists have formed the Stop The Murphy Bill Political Action Committee (PAC). This PAC was organized to advocate for the civil rights of persons with mental health histories by pushing back against the highly controversial Helping Families in Mental Health Crisis Act, HR3717, introduced by Rep. Tim Murphy.
› Verified 5 days ago
| Entity Name | Downtown Bronx Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689618407 PECOS PAC ID: 9638082746 Enrollment ID: O20031106000016 |
News Archive
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
To influence congressional candidates up for election this November, a group of mental health activists have formed the Stop The Murphy Bill Political Action Committee (PAC). This PAC was organized to advocate for the civil rights of persons with mental health histories by pushing back against the highly controversial Helping Families in Mental Health Crisis Act, HR3717, introduced by Rep. Tim Murphy.
› Verified 5 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
To influence congressional candidates up for election this November, a group of mental health activists have formed the Stop The Murphy Bill Political Action Committee (PAC). This PAC was organized to advocate for the civil rights of persons with mental health histories by pushing back against the highly controversial Helping Families in Mental Health Crisis Act, HR3717, introduced by Rep. Tim Murphy.
› Verified 5 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
To influence congressional candidates up for election this November, a group of mental health activists have formed the Stop The Murphy Bill Political Action Committee (PAC). This PAC was organized to advocate for the civil rights of persons with mental health histories by pushing back against the highly controversial Helping Families in Mental Health Crisis Act, HR3717, introduced by Rep. Tim Murphy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond Chiong, DO 36 Prospect Ave, Valhalla, NY 10595-1910 Ph: () - | Raymond Chiong, DO 36 Prospect Ave, Valhalla, NY 10595-1910 Ph: (914) 761-6257 |
News Archive
CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.
To influence congressional candidates up for election this November, a group of mental health activists have formed the Stop The Murphy Bill Political Action Committee (PAC). This PAC was organized to advocate for the civil rights of persons with mental health histories by pushing back against the highly controversial Helping Families in Mental Health Crisis Act, HR3717, introduced by Rep. Tim Murphy.
› Verified 5 days ago
Richard G. Mccarrick, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 40 Sunshine Cottage Rd, New York Medical College, Administration Bldg. Room 143, Valhalla, NY 10595 Phone: 914-594-4503 Fax: 914-594-4565 | |
Joan R Youchah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Behavioral Health Center N312, Valhalla, NY 10595 Phone: 914-493-7124 Fax: 914-493-1015 | |
Dr. Shakeeb Hussain, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 E Stevens Ave Ste 108, Valhalla, NY 10595 Phone: 845-471-1807 | |
Dr. Houshang Shahim, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 20 Plaza West, Cedarwood Hall, Valhalla, NY 10595 Phone: 914-493-8155 Fax: 914-493-1973 | |
Stuart Alex Brill, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 913-660-2683 | |
Santhi S Ratakonda, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Woods Rd, Valhalla, NY 10595 Phone: 914-493-7000 | |
Iqbal Q Sheikh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Nymc, Behavioral Health Center N312, Valhalla, NY 10595 Phone: 914-493-7124 Fax: 914-493-1015 |